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Summary. Several surgical techniques are used
nowadays as a severe treatment for obesity and diabetes
mellitus type 2. These techniques are aggressive due to
drastic changes in the nutrient flow and non-reversible
modifications on the digestive tube. In this paper we
present the effects of a massive intestinal resection on
the pancreas. Results have shown that short bowel
technique is less aggressive to normal anatomy and
physiology of the intestinal tract than Gastric bypass or
biliopancreatic diversion (e.g.). In this paper we
reproduce a model of short bowel syndrome (SIC), with
similar surgical conditions and clinical complications as
seen in human cases. This work was conducted on
normal Wistar rats, with no other concurrent factors, in
order to determine the effects on normal pancreas islets.
We measured pancreatic implications by histo-
morphometric studies, which included beta-cell mass by
immunocytochemistry, and apoptosis/proliferation test
with TUNEL technique and Ki-67. Briefly, we reported
on an increased relative area of the islets of the pancreas,
as well as an increase in the average size of islets in the
SIC versus the control group. Furthermore we stated that
this increase in size of the pancreatic islets is due to the
mechanisms of proliferation of beta cells in animals
undergoing SIC. These goals could reveal a direct
influence of surgical modification of the digestive tract
over the pancreatic beta cell homeostasis. In this sense,
there are many potential stimulators of intestinal
adaptation, including peptide hormones and growth
components which are associated or involved as
effectors of the endocrine pancreas.
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Introduction
Obesity has become a major public health problem
due to its prevalence, costs and negative effects on
health. The World Health Organization predicts that in
the year 2015 obesity, as defined by a body mass index
(BMI) of at least 30 kg/m2, will affect approximately
700 million people around the world. 
Type 2 diabetes mellitus (T2DM), characterized by
insulin resistance and relative insulin insufficiency can
be considered one of the most important obesity-
associated pathologies. It is present in more than one-
fifth of obese adults and, as reported in a meta-analysis
by Buchwald et al. (2004), approximately 20% of gastric
bypass candidates suffer type 2 Diabetes. It usually
affects people over the age of 40, but it may also occur
earlier, especially in populations with high diabetes
prevalence. The prevalence of T2DM is currently
estimated in 5-10% of the population with an increasing
global trend, especially in children and adolescents
(Wild et al., 2004). 
Bariatric surgery was first used in 1954 to induce
weight loss by the surgeons Kremen et al., based on their
observations in short bowel syndrome (SIC) patients and
other pathologies in which bowel length or gastric
capacity are surgically reduced. The same results were
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seen in experimental studies using animals since the end
of XIX century and XX century (Brenizer, 1929; Booth,
1959), and similar considerations were reported in
human studies (West et al., 1939; Meyer, 1946;
Buchwald, 1970; Casey and Martin, 1981).
Currently it represents the most important
therapeutic alternative to induce weight loss in cases of
morbid obesity. Obese patients suffering from T2DM,
who undergo bariatric surgery, experience diabetes
remission in a significant percentage of cases.
Surprisingly, diabetes remission happens before weight
loss, suggesting a relationship between digestive tract
modification and changes in glucose homeostasis. The
incidence of diabetes remission varies according to the
surgical technique applied. In the meta-analysis by
Buchwald et al. (2009), including a total of 135,246
patients studied for 16 years, found diabetes remission in
56.7% of patients who underwent laparoscopic
adjustable gastric banding, 80.3% of patients who
underwent gastric bypass, 79.7% of patients who
underwent gastroplasty and 95.1% of patients who
underwent biliopancreatic diversion/duodenal switch.
Restrictive and malabsortive components are
normally present in bariatric surgery procedures and
both of them are considered responsible for the anti-
diabetogenic effects. The mechanisms responsible for
these remain unknown. Theories to explain these anti-
diabetes effects may be classified in three different
groups for academic purposes: the Ghrelin hypothesis
postulates that compromised secretion of the hormone
Ghrelin from the stomach might be related to the glucose
homeostasis improving effects of some types of bariatric
surgeries (Cummings and Shannon, 2003; Holdstock et
al., 2003). The lower intestinal hypothesis proposes an
accentuated GLP-1 secretion due to expedited delivery
of unabsorbed nutrients in the distal gut as anti-diabetes
stimulus (Koopsmans et al., 1984; Bose et al., 2009;
Eickhoff et al., 2014). The upper Intestinal hypothesis
suggests that preventing the contact of ingested nutrients
with a segment of the proximal small intestine, mainly
the duodenum, exert a direct anti diabetic effect via
unidentified mechanisms (Rubino and Marescaux, 2004;
Duan et al., 2014; Salinari et al., 2014). However, none
of these theories alone can totally explain the observed
improvement in glucose homeostasis attained with both
restrictive and malabsortive procedures, although an
altered secretion of gastrointestinal (GI) hormones may
be the basis of these effects.
Surgical modification of the GI tract affects the
secretion of different GI hormones and peptides such as
Ghrelin and GLP-1. It is well known that these
hormones have the capacity to induce proliferation of
beta cells (Drucker, 2003; Kerem et al, 2009; Doss and
Smith, 2012). However, very little is known about the
effects of bariatric surgery on pancreatic beta cell
turnover or even insulin resistance (Salinari et al., 2014).
In our work, we aimed to investigate the potential
effects of a purely malabsortive technique with
preserved duodenum in pancreatic beta cell proliferation.
We performed a surgical reduction of 50% of the central
portion of the small intestine in a set of non-obese
Wistar rats to avoid interference with presurgical insulin
resistance (Collantes-Perez et al, 2004) and evaluated its
effects on beta cell proliferation/apoptosis balance. An
increase of pancreatic islet relative area and beta cell
proliferation was observed in intervened animals,
revealing a direct effect of digestive tract alteration on
pancreatic beta cell homeostasis. 
Materials and methods
Animals
All animal procedures were performed with the
approval of the Cádiz University School of Medicine
(Cádiz, Spain) Committee for the Ethical Use and Care
of Experimental Animals. Wistar rats were kept under
conventional conditions in an environment-controlled
room (20-21°C, 12h light-dark cycle) with water and
standard laboratory rat chow available ad libitum.
Surgical procedures
Young adult male Wistar rats (n=12) of
approximately 250 g, were subjected to a presurgical
protocol consisting of a 24 hours fasting period. They
were then anaesthetized with isofluorane (Isoflo, Abbott
571329.8) and a surgical resection of 50% of their small
intestine was performed by laparotomy. Briefly, after
abdominal midline incision, we identified the Treitz’s
angle and the ileocecal valve as anatomical references.
The bowel between these points was exposed and
measured. We then made a resection of the central 50%,
followed by an end-to-end anastomosis with 5-0
monoplane silk suture, leaving the proximal half of the
jejunum and the distal half of the ileum intact (Fig. 1).
Short bowel syndrome group consisted of 6 animals.
Sham group underwent the laparotomy and bowel
section and anastomosis without resection (n=6).
Overnight, post-operatory rats only received water. For
the next five months animals were fed with regular rat
chow and their weight was monitored every two weeks.
Tissue preparation and Immunohistochemistry
Animals were sacrificed five months after surgery
by an intraperitoneal Chloral Hydrate overdose to avoid
unnecessary pain. Pancreas were immediately removed
and fixed in Bouin’s solution overnight at 4°C, followed
by a 72 hours postfix in Formalin at room temperature
(Pearse, 1968). They were then rehydrated using graded
alcohols and xylol and embedded in paraffin. Serial 10
μm-microtome sections were obtained, mounted on
poly-lysinated slides, and stored until processed.
Sections were deparaffinized in xylol and rehydrated
in degraded alcohol series and distilled water.
Endogenous peroxidase activity was inhibited with 3%
H2O2 solution treatment for 30 min at room temperature.
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Sections were then washed twice in phosphate buffer
saline (PBS, pH 7.4).
To perform histomorphometric studies, insulin was
stained using a mouse anti-insulin monoclonal antibody
(Sigma, I-2018), a peroxidase conjugated goat anti
mouse IgG antibody plus streptavidin complex (Sigma,
Mouse Extra-2). Samples were revealed with a solution
of 0.3 mg/ml of 3,3’Diaminobenzidine (Sigma, D5905)
in the presence of 0.2 µl/ml of H2O2 under microscopic
control. To determine beta-cell area, the insulin-positive
areas were measured using a microscope equipped with
a digital camera and the image analysis Cell D software
(Olympus, Hamburg, Germany). The investigators who
performed the measurements did not know which
experimental group the samples belonged to. Beta-Cell
area was expressed as the insulin-positive area/total
pancreatic area ratio.
Detection of proliferation and apoptosis
Proliferation was assessed by double
immunostaining using polyclonal rabbit anti-Ki67
(ABIN1582250) and monoclonal mouse anti-insulin
(Sigma, I-2018) antibodies. After deparaffination and
rehydration, pancreatic sections were incubated for 30
min with 0.2% Triton x-100 in PBS containing 3% BSA
to permeabilize the tissue, and incubated overnight at
4°C with anti-Ki67 and anti-insulin antibodies. Stained
sections were revealed using anti-rabbit IgG antibody
(Alexa-488 conjugated) and anti-mouse IgG (Alexa-546
conjugated) antibodies (Molecular Probes, Inc., Eugene,
OR). 
Beta-Cell apoptosis was determined using the Dead-
End Fluorometric-terminal deoxynucleotidyltransferase-
mediated 2’-deoxyuridine-5’-triphosphate nick end
labelling (TUNEL) System (Promega, Madison,WI)
according to the manufacturer’s instructions, and
simultaneously stained using monoclonal mouse anti-
insulin (Sigma-Aldrich), revealed with an anti-mouse
IgG (Alexa-546 conjugated) antibody (Molecular Probes
Inc; Eugene, OR, USA). 
To determine the proliferating or apoptotic fraction,
insulin+/Ki67+ cells or insulin+/TUNEL+ cells and
islets area were quantified in a total of 25 islets per
condition. Slides were analyzed using a fluorescence
microscope equipped with a digital camera and the
image analysis Cell-D software (Olympus, Hamburg,
Germany). The results were expressed as number of
insulin+ /Ki67+ cells/mm2 of islet or insulin+ /TUNEL+
cells/mm2 of islet.
Statistical analyses
Results are presented as means±SEM of
measurements performed in at least five animals per
group. Statistical comparisons were performed either by
Mann-Whitney’ U test or by ANOVA followed by
Sheffe’s test. All p values less than or equal to 0.05 were
considered statistically significant.
Results
Effect of surgery in weight gain
To evaluate the effect of small bowel resection in
animal weight gain, this parameter was quantified every
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Fig. 1. Remnant small intestine after surgical
procedure. The suture (an: anastomosis) is
clearly seen at the junction between jejunum
(JE) and ileum (IL), marked with an arrow. AC
marks the ascending colon.
two weeks, for five months after surgery. As explained
in Fig. 2, no statistically differences were observed
between sham surgery and intestinal resection in weight
gain, although animals that suffered the SIC showed a
smaller increase in the normal rate of weight gain
compared to controls.
Changes induced by small bowel resection in beta cell
population
Insulin positive pancreatic area/total pancreatic area
ratio was evaluated five months after surgery in paraffin
embedded pancreatic tissue sections immunostained
using a mouse anti-insulin antibody (Fig. 3). A
significant enhancement in insulin positive pancreatic
area/total pancreatic area ratio was observed in the
experimental group with intestinal resection compared
with Sham rats (Fig. 4A).
In addition, we analyzed total number of islets/total
pancreatic area (mm2) and an increment in this ratio in
the group of rats that underwent intestinal resection was
also observed five months after surgery (Fig. 4B). With
these figures we described that the islets appeared larger
in the SIC against the sham group, and the number of
islets was increased, although this fact was not
statistically significant. 
Effect of small bowel resection in beta cell turnover
To evaluate the role of beta cell proliferation in
relative islet area increment observed after surgery, the
percentage of proliferating insulin-positive cells was
quantified. We used paraffin embedded pancreatic tissue
sections taken from rats with intestinal resection and
sham surgery (Fig. 5). These proliferative beta cells were
stained with anti-insulin/ki67 antibodies. An increase in
ki67 positive/insulin positive cell numbers was observed
in rats with intestinal resection in relation to control
animals five months after the intestinal resection (Fig.
6).
Changes in beta cell apoptosis ratio could also
contribute to these modifications in islet relative area.
For this reason, TUNEL technique and insulin staining
were simultaneously used to evaluate the beta cell
apoptosis ratio (Fig. 7). No significant differences were
found in beta cell apoptosis rate between experimental
groups five months after intestinal resection (Fig. 8).
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Fig. 3. Insulin-positive immunostained islets, counterstained with haematoxylin. A. Control sample. B. SIC sample. Larger islets were observed in the
short bowel syndrome.
Fig. 2. Animal weight was quantified every two weeks and weight gain
(in grams) (Y axis) is represented in both experimental groups along
time (X axis) as mean ± SEM. The figure showed a pattern of weight
gain starting 4 weeks after surgery. Point 1 of the X-axis represents the
weights of the rats at surgery time. In the first two weeks after surgery
there was no increase in weight. Both experimental groups showed a
decrease in weight in these weeks, due to surgical stress (point 2 of the
X axis). No-significant difference was observed between both groups.
The figure shows a delay between the last point and sacrifice, due to the
experimental procedure.
Changes induced by surgery in pancreatic islet size
distribution
The effect of surgery on the size of pancreatic islets
distribution was evaluated in paraffin embedded tissue
sections of pancreas immunostained with mouse anti-
insulin antibody. We observed a significant enhancement
in the number of large pancreatic islets (with areas
>5000 μm2) in resected rats compared with Sham rats.
No different values were observed in other ranks of islet
size between both groups (Fig. 9).
These data reaffirmed that observed in the other
figures and results, in the sense that the main mechanism
related to beta mass expansion in SIC must be
proliferation rather than neogenesis. Proliferation of pre-
existing beta cells increased the area of islets, but not the
number of islets (Fig. 4), and for this reason the
immunohistological analysis showed an increase of large
islets in the SIC (Fig. 9). Instead, the number of small
islets in the pancreas would be related through a
mechanism of transdifferentiation of the epithelial ducts
or stem cells.
Discussion
The positive direct effects of bariatric surgery
techniques on the clinical T2DM course are well known
and there are a set of hypothesis to explain them. One of
the most important hypothesis presents duodenal
exclusion as a major inductor of changes that result in
glucose homeostasis improvement. These effects take
place short a time after surgical intervention (Lautz et
al., 2011; Schauer et al., 2014). In this study we used an
experimental surgery in which the entire duodenum is
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Fig. 4. A. Insulin positive pancreatic area/total
pancreatic area ratio is presented in bar graph
as means ± SEM. *P≤0.05. B. Number of
pancreatic islets in relation to pancreatic area
was determined and represented as mean
values ± SEM. Thus, in these figures we
reported that the islets appeared larger in the
short bowel syndrome against the sham group.
There was an increase in number of islets, but
these data were not statistically significant.
These data were consequent with cellular
proliferation of preexisting beta cells. A
neogenesis process in the SIC would be related
with an increased in the number of islets,
generated from pancreatic ducts.
Fig. 5. Proliferating insulin positive cells stained with anti-Ki67 antibody. A. Control sample. B. SIC sample. The number of insulin positive cells, which
express the protein Ki67 (green-fluorescent Alexa Fluor 488) related to proliferation process was increased in the SIC rats.
preserved as well as the proximal half of the jejunum
and distal half of the ileum, representing a resection of
approximately 50% of the total length of the intestine
(Collantes-Pérez et al., 2004). We performed this surgery
on normal weight Wistar rats, because if we used an
animal model of obesity, insulin resistance or even
diabetes, the effects on glucose homeostasis and
pancreatic beta cell apoptosis/proliferation balance could
have been influenced by the presurgical condition. By
using normal healthy weight animals, the changes
observed can only be interpreted as a direct effect of the
surgery itself.
Various diseases require a surgical resection of a
variable length of the small intestine in humans, and
their nutritional consequences have been well studied.
Necrotizing enterocolitis and intestinal atresia in
children, as well as vascular thrombosis, malignancies
and Crohn’s disease in adults are the most frequent
indications of intestinal resection. Our surgical
experience in these cases has demonstrated that
resections of up to 50% may be well tolerated without
the need for nutritional support. Our data on animal
weight monitoring during the study is in agreement with
this observation in humans, since no surgery-induced
changes in weight gain were found (Fig. 2).
We examined the histomorphometric features of
pancreatic islets five months after surgery, comparing
sham and 50% small intestine resected animals. The
experimental group with the bowel resection showed a
significant increment of relative area of pancreatic islets
and islet number (Fig. 4A,B). Both figures showed that
the islets appeared larger in the SIC against the Sham
group, but there was no increase in the number of islets
in either group. These data were related to the pancreas
total area. These findings could be the consequence of a
cellular mechanism of proliferation, where beta cells
contribute homogeneously to the islets area. The
proliferation increases the beta cell mass from the
preexisting beta cells (Yesil and Lammert, 2008).
Meanwhile, the neogenesis process, which would be
related to an increase in the number of small islets
generated from stem cells or epithelial cells located in
the pancreatic ducts, is not coincident with our
observations. 
To clarify the mechanism underlying the observed
islet area increment, pancreatic beta cell proliferation
and apoptosis were quantified. No surgery induced
changes were observed in beta cell apoptosis rate (Fig.
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Fig. 7. TUNEL technique. A. Control sample. B. Some isolated positive cells (green-fluorescent Alexa 488) in a SIC sample. Insulin positive cells
stained in islet with red-fluorescent (Alexa Fluor 546).
Fig 6. Proliferating beta cells were quantified in pancreas sections from
rats with intestinal resection and sham five months after surgery. Beta
cell proliferation rate is shown in bar graph as means ±SEM, where the
Y axis represents the number of Ki 67 positive/insulin positive cells per
islet area expressed in mm2. *P<0.05. Thus, these data show that in the
bowel resection the number of proliferating beta cells increased
compared to surgical controls. This data was statistically significant.
8). On the other hand, beta-cell proliferation rate was
significantly higher in the experimental animals that
underwent the surgical resection (Fig. 6). The sum of
these events could explain the increment of islet area and
number. An increase of total pancreatic islet area in
response to different stimulus is due to both neogenesis
and beta cell replication processes (Yesil and Lammert,
2008; Bonner-Weir et al., 2010). An indirect
measurement of the participation of neogenesis and beta
cell replication in islet area increment is the study of islet
size distribution. An increment in beta cell clusters
and/or small islets indicates a major participation of
neogenesis in islet area increment, while an increment of
large size islets suggests an increase in beta cell
replication as the main mechanism responsible for the
observed islet area increment. In our study, a 50% of
small intestine resection preserving duodenum, proximal
jejunum and distal ileum, induced a long term increment
of large size islet number (Fig. 9). As stated before, this
observation suggests that beta cell replication is the main
mechanism implicated in surgery induced islet area
increment. 
Some patients suffer severe hypoglycemic episodes
after bariatric surgery for morbid obesity. To control
these episodes, patients often require partial
pancreatectomy. Pathological studies of the resected
pancreatic portions show typical images of
nesidioblastosis (Service et al., 2005). Although no
nesidioblastosis images were observed in our study
group, we found an increased islet area and number,
which could suggest a different stage of a common
process. Recently, the effects of intestine alteration in
rodent beta cell functionality have been studied using
different surgical models. Isolated islets from duodenal-
jejunal bypass performed on Western diet obese Wistar
rats have shown an enhancement in beta cell glucose
responsiveness (Araujo et al., 2012). This is in
accordance with data from GK rats subjected to
duodenal-jejunal exclusion, in which pancreatic islet
insulin mRNA expression was higher than in controls
(Donglei et al., 2012). Another feature supporting the
duodenal-jejunal bypass induced improvement in
glucose homeostasis in GK has been recently reported
by Speck et al. (2011). They have reported an increment
of beta cell area and a reduction of islet fibrosis induced
by surgery. Similar results have been obtained in rodents
and humans after Roux–en-Y gastric bypass (Li et al..
2010; Rabiee et al., 2011; Yu et al., 2013). A common
feature among these reports was duodenal exclusion,
coherent with the upper intestinal hypothesis. The main
problem with duodenal exclusion to the transit of
nutrients is the adverse effect on the absorption of
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Fig. 9. Size distribution of islets was calculated
in pancreatic sections from rats with intestinal
resection and sham five months after surgery,
by quantifying islet number belonging to each
area value interval and is represented in bar
graph as means ± SEM of islet number.
*P<0.05. These data showed that the islets not
only were increased in number in SIC, but they
were larger than in surgical control. When we
grouped the islets by the size of the area, the
graph showed that in the Sham group the islets
used to be between a wide ranges of 2000-
10000 μm2. Meanwhile, in SIC an abundant
number of islets presented a large area
superior to 0.01 mm2
Fig. 8. Apoptotic beta cells were quantified in pancreatic sections from
rats with intestinal resection and sham five months after surgery.
Apoptotic beta cell ratio is presented in bar graph as means ±SEM of
TUNEL positive/insulin positive cells per islet area expressed in mm2.
There were not differences between groups.
different micronutrients which may have negative long
term consequences. Instead of this, in our surgical model
the duodenal segment is preserved. Furthermore the
nutritional status is maintained without other undesirable
effects such as chronic diarrhea, dumping syndrome, etc.
In conclusion, using an animal model in which
overweight is not a participating variable, our work
demonstrates the effect of a non-weight-loss-inducing
intestinal surgery in beta cell increase rate. This effect is
mediated by duodenal exclusion. Our data suggest that
other different mechanisms than those involved in the
proximal gut hypothesis should be implicated in the
events of turnover and expansion of adult beta cell mass.
Moreover, the data suggest that the use of this surgical
technique with low effects on nutrition can be a good
approach to physiopathological mechanism in T2DM,
mainly in patients in whom obesity is not an associated
problem.
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